Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons

• Main Authors: Tremblay G (Author), Westley T (Author), Cappelleri JC (Author), Arondekar B (Author), Chan G (Author), Bell TJ (Author), Briggs A (Author)
• Formato: Libro
• Publicado: Dove Medical Press, 2019-09-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Gabriel Tremblay1, Tracy Westley1, Joseph C Cappelleri2, Bhakti Arondekar2, Geoffrey Chan2, Timothy J Bell2, Andrew Briggs3 1Purple Squirrel Economics, New York, NY, USA; 2Pfizer Inc, New York, NY, USA; 3William R Lindsay Chair of Health Economics, Health Economics and Technology Assessment, Institu...